CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Cellipont Bioservices' Texas Facility Has Supported Six Client Projects Expected to Reach IND Submission in 2026

Positive
AI Analysis

Summary

Cellipont Bioservices announced that its Texas facility has supported six client projects expected to reach IND submission in 2026, highlighting its cell therapy manufacturing capabilities.

Importance:3/10
Sentiment:
0.50
CDMOcell therapymanufacturingIND submission

Read the original article

Published by PR Newswire Biotech on September 3, 2026 2:28 PM

Read Original